UNSPSC 51101908: Artemether

This classification denotes an antimalarial agent with the molecular formula C16H26O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C7D6T3H22J, chemically known as 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar)-, (+)- but generally known as artemether, which bears US NIH Compound Identifier 68911. European Medicines Agency schedules Artemether in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05574MIG.

UNSPSC 51101908 Artemether is a Commodity code for a specific antimalarial pharmaceutical product, but the recent state and local contract opportunities tagged under this code do not reflect procurement of artemether itself. Instead, the opportunities show public health agencies sourcing unrelated pharmaceuticals — antibiotics, naloxone, and drug deactivation systems — through piggyback awards and competitive bid processes. The code appears to be a catch-all or mislabeled classification within state and local procurement systems, not an active procurement line for artemether as typically defined. State and local issuing bodies soliciting under this code include county health authorities and state departments of public health, working through cooperative purchasing consortiums such as MMCAP Infuse to aggregate demand and leverage negotiated supplier contracts for emergency preparedness and community health initiatives.

The recent activity spans Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (bid number 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with two renewal options. Seminole County, Florida released an IFB (60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023, with fixed-fee award criteria and potential FEMA funding. Neither opportunity directly procures artemether, and the code shows little recent alignment with its stated pharmaceutical scope.